Gabelli Funds LLC Sells 3,760 Shares of HCA Healthcare, Inc. $HCA

Key Points

• Gabelli Funds LLC reduced its stake in HCA Healthcare, Inc. by 8.0%, now holding 43,220 shares valued at approximately $14.94 million.
• HCA Healthcare's quarterly earnings exceeded expectations, reporting $6.84 EPS and $18.61 billion in revenue, showing a 6.4% year-over-year revenue increase.
• The company declared a quarterly dividend of $0.72 per share, with a dividend yield of 0.7%, payable on September 30th.

Gabelli Funds LLC reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 8.0% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 43,220 shares of the company's stock after selling 3,760 shares during the quarter. Gabelli Funds LLC's holdings in HCA Healthcare were worth $14,935,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in HCA. Cheviot Value Management LLC bought a new stake in shares of HCA Healthcare during the first quarter worth about $26,000. Atwood & Palmer Inc. bought a new stake in shares of HCA Healthcare during the first quarter worth about $28,000. Bartlett & CO. Wealth Management LLC grew its stake in shares of HCA Healthcare by 888.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after acquiring an additional 80 shares in the last quarter. ORG Partners LLC grew its stake in shares of HCA Healthcare by 344.0% in the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after acquiring an additional 86 shares in the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. grew its stake in shares of HCA Healthcare by 75.8% in the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock worth $40,000 after acquiring an additional 50 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Performance

HCA traded down $3.17 on Friday, hitting $404.11. The company's stock had a trading volume of 996,401 shares, compared to its average volume of 1,129,223. The company's 50 day simple moving average is $376.92 and its 200-day simple moving average is $356.64. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The firm has a market cap of $94.56 billion, a P/E ratio of 16.99, a price-to-earnings-growth ratio of 1.27 and a beta of 1.39.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same period last year, the business earned $5.50 earnings per share. HCA Healthcare's revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is 12.11%.

Analysts Set New Price Targets

Several analysts have recently issued reports on HCA shares. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. JPMorgan Chase & Co. upped their price objective on HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a research note on Monday, August 4th. Wells Fargo & Company reduced their price objective on HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating for the company in a research note on Thursday, August 14th. Barclays reduced their price objective on HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating for the company in a research note on Monday, July 28th. Finally, Truist Financial upped their price objective on HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a research note on Wednesday, July 16th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $401.83.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.